Malignant Lymphoma of Soft Tissue in an HIV-1+ Patient: A Rare Site for Primary Malignant Lymphoma with Implications for Treatment
Smith K, Skelton H, Ruiz N, Laskin W, Wagner K. Malignant Lymphoma of Soft Tissue in an HIV-1+ Patient: A Rare Site for Primary Malignant Lymphoma with Implications for Treatment. American Journal Of Dermatopathology 1995, 17: 403-406. PMID: 8600808, DOI: 10.1097/00000372-199508000-00018.Peer-Reviewed Original ResearchConceptsSoft tissue lymphomaHIV-1 diseaseTissue lymphomaLocal therapyMalignant lymphomaSoft tissueHigh-grade soft tissueHIV-1-positive patientsHuman immunodeficiency virus type 1Immunodeficiency virus type 1Complete systemic evaluationEvidence of tumorPrimary malignant lymphomaHigh-grade lesionsFatal opportunistic infectionLarge reported seriesVirus type 1Extranodal lymphomaBetter prognosisOpportunistic infectionsSurgical excisionHodgkin's lymphomaReported seriesHIV-1General populationDesmoplastic malignant melanoma
Skelton H, Smith K, Laskin W, McCarthy W, Gagnier J, Graham J, Lupton G. Desmoplastic malignant melanoma. Journal Of The American Academy Of Dermatology 1995, 32: 717-725. PMID: 7722014, DOI: 10.1016/0190-9622(95)91448-x.Peer-Reviewed Original ResearchConceptsDisease-free survival ratesDesmoplastic malignant melanomaMalignant melanomaSurvival rateHistologic featuresCases of DMMOverall histologic featuresDisease-free survivalArmed Forces InstituteBetter prognosisHMB-45Histologic findingsImmunohistochemical evaluationTumor locationImmunohistochemical studyTumor depthUncommon variantBiologic potentialStromal mucinAdequate materialMelanomaTumorsRelative rarityPatientsNeural differentiation